294 related articles for article (PubMed ID: 21029700)
21. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.
Akazawa K; Tamaki Y; Taguchi T; Tanji Y; Miyoshi Y; Kim SJ; Ueda S; Yanagisawa T; Sato Y; Tamura S; Noguchi S
Breast J; 2006; 12(2):130-7. PubMed ID: 16509837
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.
Loo CE; Straver ME; Rodenhuis S; Muller SH; Wesseling J; Vrancken Peeters MJ; Gilhuijs KG
J Clin Oncol; 2011 Feb; 29(6):660-6. PubMed ID: 21220595
[TBL] [Abstract][Full Text] [Related]
23. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
[TBL] [Abstract][Full Text] [Related]
24. Preoperative carboplatin-paclitaxel-bevacizumab in triple-negative breast cancer: final results of the phase II Ca.Pa.Be study.
Guarneri V; Dieci MV; Bisagni G; Boni C; Cagossi K; Puglisi F; Pecchi A; Piacentini F; Conte P
Ann Surg Oncol; 2015 Sep; 22(9):2881-7. PubMed ID: 25572687
[TBL] [Abstract][Full Text] [Related]
25. Tumor reduction rate predicts early recurrence in patients with breast cancer failing to achieve complete response to primary chemotherapy.
Nagashima T; Sakakibara M; Sangai T; Kazama T; Nakatani Y; Miyazaki M
Breast Cancer; 2010 Apr; 17(2):125-30. PubMed ID: 19459030
[TBL] [Abstract][Full Text] [Related]
26. MRI and conservative treatment of locally advanced breast cancer.
Julius T; Kemp SE; Kneeshaw PJ; Chaturvedi A; Drew PJ; Turnbull LW
Eur J Surg Oncol; 2005 Dec; 31(10):1129-34. PubMed ID: 15905068
[TBL] [Abstract][Full Text] [Related]
27. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E
Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
[TBL] [Abstract][Full Text] [Related]
28. Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study.
Kumar M; Jagannathan NR; Seenu V; Dwivedi SN; Julka PK; Rath GK
J Magn Reson Imaging; 2006 Aug; 24(2):325-32. PubMed ID: 16786567
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging enhancement features before and after neoadjuvant chemotherapy in patients with breast cancer: a predictive value for responders.
Kang DK; Kim TH; Han TS; Kim KS; Yim H
J Comput Assist Tomogr; 2013; 37(3):432-9. PubMed ID: 23674017
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of dynamic contrast-enhanced magnetic resonance imaging in evaluating clinical responses to neoadjuvant chemotherapy in breast cancer.
Liu YH; Ye JM; Xu L; Huang QY; Zhao JX; Duan XN; Qin NS; Wang XY
Chin Med J (Engl); 2011 Jan; 124(2):194-8. PubMed ID: 21362364
[TBL] [Abstract][Full Text] [Related]
31. Effective factors to raise diagnostic performance of breast MRI for diagnosing pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
Choi BB; Kim SH
Acta Radiol; 2015 Jul; 56(7):790-7. PubMed ID: 24951616
[TBL] [Abstract][Full Text] [Related]
32. Histologic breast cancer extent after neoadjuvant chemotherapy: comparison with multidetector-row CT and dynamic MRI.
Tozaki M; Uno S; Kobayashi T; Aiba K; Yoshida K; Takeyama H; Shioya H; Tabei I; Toriumi Y; Suzuki M; Kawakami M; Fukuda K
Radiat Med; 2004; 22(4):246-53. PubMed ID: 15468945
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging evaluation of residual ductal carcinoma in situ following preoperative chemotherapy in breast cancer patients.
Choi HK; Cho N; Moon WK; Im SA; Han W; Noh DY
Eur J Radiol; 2012 Apr; 81(4):737-43. PubMed ID: 21300498
[TBL] [Abstract][Full Text] [Related]
34. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Teruel JR; Heldahl MG; Goa PE; Pickles M; Lundgren S; Bathen TF; Gibbs P
NMR Biomed; 2014 Aug; 27(8):887-96. PubMed ID: 24840393
[TBL] [Abstract][Full Text] [Related]
35. Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy.
Chen X; Moore MO; Lehman CD; Mankoff DA; Lawton TJ; Peacock S; Schubert EK; Livingston RB
Acad Radiol; 2004 Oct; 11(10):1115-24. PubMed ID: 15530804
[TBL] [Abstract][Full Text] [Related]
36. [MRI evaluation of primary chemotherapy response in breast cancer].
Vénat-Bouvet L; Desfougères M; Aubard Y; Mollard J; Fermeaux V; Genet D; Labourey JL; Martin J; Lebrun-Ly V; Maubon A; Tubiana-Mathieu N
Bull Cancer; 2004 Sep; 91(9):721-8. PubMed ID: 15544998
[TBL] [Abstract][Full Text] [Related]
37. MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy.
Belli P; Costantini M; Malaspina C; Magistrelli A; LaTorre G; Bonomo L
Clin Radiol; 2006 Nov; 61(11):946-53. PubMed ID: 17018307
[TBL] [Abstract][Full Text] [Related]
38. Extramedullary hematopoiesis in breast after neoadjuvant chemotherapy for breast carcinoma.
Wang J; Darvishian F
Ann Clin Lab Sci; 2006; 36(4):475-8. PubMed ID: 17127738
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI.
Kim HJ; Im YH; Han BK; Choi N; Lee J; Kim JH; Choi YL; Ahn JS; Nam SJ; Park YS; Choe YH; Ko YH; Yang JH
Acta Oncol; 2007; 46(7):996-1003. PubMed ID: 17851879
[TBL] [Abstract][Full Text] [Related]
40. Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size.
Kim YS; Chang JM; Moon HG; Lee J; Shin SU; Moon WK
Ann Surg Oncol; 2016 Apr; 23(4):1135-42. PubMed ID: 26628432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
